<DOC>
	<DOCNO>NCT00926965</DOCNO>
	<brief_summary>Previous researcher indicate impaired cognitive flexibility primary factor distinguish patient without tardive dyskinesia ( TD ) 1 , cognitive dysfunction correlate positively severity TD2 . Longitudinal data raise possibility association cognitive dysfunction TD may reflect organic vulnerability rather state marker movement disorder `` tardive dementia '' 3 . Atypical antipsychotic report alleviate severity TD4 improve neurocognitive function separately5 . But researcher ever investigate correlation two effect simultaneously . This randomized , single-blind control study compare effect atypical antipsychotic TD , neurocognitive function associate factor change .</brief_summary>
	<brief_title>Tardive Dyskinesia Cognitive Function</brief_title>
	<detailed_description>Eighty chronic schizophrenia inpatient receive conventional antipsychotic one year , meet Schooler Kane 's criterion persistent TD enrol study . The subject randomize three group : olanzapine , amisulpride FGA ( first generation antipsychotic ) control group . Neurocognitive function assess use Wisconsin Card Sorting Test ( WSCT ) Continuous Performance test ( CPT ) baseline , 12th week 24th week . Clinical successive rating perform Brief psychiatric Rating Scale ( BPRS ) , AIMS ( Abnormal Involuntary Movement Rating Scale ) , Simpson-Angus Rating Scale ( SAS ) , Udvalg Kliniske Undersogelser side effect rating ( UKU ) Barnes akathesia scale ( BAS ) .To evaluate influence prognostic factor tardive dyskinesia neurocognitive function control potential confounding variable , longitudinal analysis repeat measure data conduct use generalize estimate equation model ( GEE ) .</detailed_description>
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<criteria>schizophrenia inpatient receive conventional antipsychotic one year , meet Schooler Kane 's criterion persistent TD . mental retardation , organic mental disorder , pregnancy allergy trial drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>tardive dyskinesia</keyword>
	<keyword>neurocognitive function</keyword>
</DOC>